Quick Answer
IDEAYA Biosciences, Inc. reported Operating Income of -$159.31 million for fiscal year 2025.
IDEAYA Biosciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$159.31M | +51.3% |
| 2024 | -$326.98M | -143.2% |
| 2023 | -$134.43M | -115.1% |
| 2022 | -$62.50M | -24.3% |
| 2021 | -$50.27M | -42.2% |
| 2020 | -$35.34M | +20.2% |
| 2019 | -$44.27M | -21.6% |
| 2018 | -$36.42M | -152.2% |
| 2017 | -$14.44M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $108.45M | +262.1% | +222.1% |
| June 30, 2025 | -$88.81M | -36.8% | -5.2% |
| March 31, 2025 | -$84.39M | -65.4% | -26.2% |
| September 30, 2024 | -$66.89M | -99.5% | -3.0% |
| June 30, 2024 | -$64.93M | -98.5% | -27.3% |
| March 31, 2024 | -$51.02M | -94.1% | -52.2% |
| September 30, 2023 | -$33.53M | -5179.7% | -2.5% |
| June 30, 2023 | -$32.71M | -45.4% | -24.5% |
- IDEAYA Biosciences, Inc. showed an increase of +51.3% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, IDEAYA Biosciences, Inc.’s operating income has declined by 1003.4% (from -$14.44 million to -$159.31 million).
- The most recent figure is from IDEAYA Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: